by TractManager | Jun 15, 2018 | Emerging Technology Report
The Inspiris Resilia is a replacement aortic valve comprised of 3 elements: Resilia tissue, VFit technology, and Carpentier-Edwards Perimount Magna Ease valve design. Carpentier-Edwards is an established, proven valve design; VFit is a new, proprietary platform that...
by TractManager | Jun 15, 2018 | Clinical Utility Evaluation
This report evaluates the clinical utility for the use of HLA-DQ2/DQ8 genotyping to rule out celiac disease (CD) in symptomatic individuals with an uncertain diagnosis.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Jun 15, 2018 | Clinical Utility Evaluation
This report evaluates the clinical utility for the use of HLA-DQ2/DQ8 genotyping to rule out celiac disease (CD) in symptomatic individuals with an uncertain diagnosis.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Jun 15, 2018 | Clinical Utility Evaluation
This report evaluates the clinical utility for the use of HLA-DQ2/DQ8 genotyping in asymptomatic relatives of individuals with celiac disease (CD).If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Jun 14, 2018 | Health Technology Assessment
Health Problem: Prostate cancer is the most common cancer diagnosis and the second leading cause of cancer-related deaths in men in the United States. Within 10 years of successful treatment for localized prostate cancer, serum prostate specific antigen (PSA) levels...
Recent Comments